Fabrizio Pane
Università degli Studi di Napoli Federico II
H-index: 75
Europe-Italy
Top articles of Fabrizio Pane
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma | Francesco Pepe Claudia Giordano Gianluca Russo Lucia Palumbo Annamaria Vincenzi | 2024/3 | |
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort | American Journal of Hematology | Carmelo Gurnari Maria Rosaria Pascale Antonio Vitale Elisa Diral Alessandro Tomelleri | 2024/2 |
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes | Annals of Hematology | Tiziano Barbui Alessandra Carobbio Valerio De Stefano Alberto Alvarez-Larran Arianna Ghirardi | 2024/2 |
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy | Cancer | Francesca Palandri Giuseppe A Palumbo Giulia Benevolo Alessandra Iurlo Elena M Elli | 2024/4/15 |
Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone … | Hematological oncology | Marco Picardi Claudia Giordano Novella Pugliese Massimo Mascolo Silvia Varricchio | 2024/1 |
Limited efficacy of 3+ 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients | Cancer Reports | Bianca Serio Francesco Grimaldi Lucia Ammirati Mario Annunziata Giovanna De Santis | 2024/4 |
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study | Hematological Oncology | Paolo Sportoletti Luca Laurenti Annalisa Chiarenza Gianluca Gaidano Elisa Albi | 2024/1 |
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study | Blood | Stefano Molica Potito Rosario Scalzulli Lydia Scarfò Attilio Guarini Roberta Murru | 2022/11/15 |
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA) | Annals of Hematology | Massimo Breccia Pier Paolo Olimpieri Simone Celant Odoardo Maria Olimpieri Fabrizio Pane | 2023/5 |
The Use of 2 nd Generation TKIs As First Line Therapy Does Not Prevent CML Related Deaths: Results of an Italian CML Campus Prospective Study in 1277 Patients Treated First … | Blood | Valentina Giai Fabio Stagno Tiziana Rosso Fausto Castagnetti Isabella Capodanno | 2023/11/2 |
Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter … | Hematological Oncology | Marco Picardi Claudia Giordano Elena Vigliar Pio Zeppa Imma Cozzolino | 2023/12 |
Liposomal doxorubicin supercharge‐containing frontline treatment for diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: preliminary results of a phase II study | Hematological Oncology | C Giordano M Picardi N Pugliese R Della Pepa A D'Ambrosio | 2023/6 |
P1041: LEUKOCYTOSIS SELECTS A SUBGROUP OF LOW‐RISK PV PATIENTS IN WHOM PHLEBOTOMY‐ALONE MAY BE INSUFFICIENT | HemaSphere | Alessandra Carobbio Alessandro Vannucchi Valerio De Stefano Arianna Ghirardi Greta Carioli | 2023/8 |
Safety of subcutaneous daratumumab in anti-CD38 monoclonal antibody-naive patients with plasma cell disorders: a multicenter real-life experience | Targeted Oncology | Danilo De Novellis Raffaele Fontana Salvatore Palmieri Roberta Della Pepa Maria Di Perna | 2023/11 |
P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT‐TERM RUX PROGNOSTIC MODEL (STR‐PM) | HemaSphere | Francesca Palandri Giuseppe Auteri Alessandra Iurlo Elena Maria Elli Simona Paglia | 2023/8 |
Pregnancy Outcome of Women with Paroxysmal Nocturnal Hemoglobinuria | Fabrizio Zullo Elisabetta Gragnano Gabriele Saccone Vincenzo Berghella Fabrizio Pane | 2023 | |
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally … | Cancers | Marco Picardi Claudia Giordano Roberta Della Pepa Novella Pugliese Maria Esposito | 2023/4/4 |
On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML) | Blood | Elisabetta Abruzzese Elena Chiara Fausto Castagnetti Mario Annunziata Carlo Gambacorti-Passerini | 2023/11/28 |
Outcome of Patients with Chronic Myeloid Leukemia in Chronic Phase Showing Clinical Resistance to Frontline Treatment with Second Generation Tyrosine Kinase Inhibitors. an … | Blood | Fabio Stagno Valentina Giai Patrizia Pregno Gabriele Gugliotta Tiziana Rosso | 2023/11/2 |
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome | Cancer | Francesca Palandri Massimo Breccia Camilla Mazzoni Giuseppe Auteri Elena Maria Elli | 2023/6/1 |
